Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 3256 AL 3270

A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD

Erichsen JM, Register TC, Sutphen C, Ma D, Gaussoin SA, Rudolph M, Rundle M, Bateman JT, Lockhart SN, Sai KKS, Whitlow C, Craft S.

Alzheimers Dement. 2025 Oct;21(10):e70704. doi: 10.1002/alz.70704.

Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers

Shaabanpoor Haghighi A, Mayeli M, Ramezannezhad E, Pouroushaninia N, Barzegar Parizi R, Nourollahi-Foumeshi M, Idelkhani N, Dadjou Z, Saeedipour N, Safaee N, Partoandaz H, Shafie M, Sadeghi M, Falahati M; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2025 Nov;62(11):14156-14166. doi: 10.1007/s12035-025-05185-w. Epub 2025 Jul 16.

Boston University Alzheimer's Disease Research Center Clinical Core: Infrastructure to facilitate research on post-traumatic Alzheimer's disease and related dementias

Alosco ML, Morrison M, Au R, Steinberg EG, Mwicigi J, Ly M, Altaras C, Lenio S, Abdennadher M, O'Connor MK, Tripodis Y, Palmisano J, Dixon D, Martin B, Schneider G, Groh JR, Ellison A, Sheppard D, Farris CW, Nowinski C, Cantu RC, Turk KW, Farrer L, Jun G, Goldstein LE, Qiu WQ, Stein TD, Budson AE, McKee AC, Mez J.

Alzheimers Dement. 2025 Sep;21(9):e70654. doi: 10.1002/alz.70654.

Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential

García-de Soto J, Castro-Mosquera M, Pouso-Diz JM, Fernández-Cabrera A, Rodríguez-Arrizabalaga M, Debasa-Mouce M, Camino-Castiñeiras J, Minguillón Pereiro AM, Aramburu-Núñez M, Romaus-Sanjurjo D, Aldrey JM, Pego-Reigosa R, Pías-Peleteiro JM, Sobrino T, Ouro A.

Int J Mol Sci. 2025 Jul 23;26(15):7068. doi: 10.3390/ijms26157068.

Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

Serna MF, Mosquera M, García-Perdomo HA.

Neuromolecular Med. 2025 Jul 25;27(1):53. doi: 10.1007/s12017-025-08866-w.

Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers

Naiyeri A, Moqadami A, Khalaj-Kondori M.

Curr Gene Ther. 2025;25(5):646-662. doi: 10.2174/0115665232338503241227111640.

Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review

Kjaergaard D, Simonsen AH, Waldemar G, Nielsen TR.

J Alzheimers Dis. 2025 Jan;103(1):81-91. doi: 10.1177/13872877241299047. Epub 2025 Jan 15.

Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer's Disease

Wu F, Li W, Lu H, Li L.

Mol Cell Proteomics. 2025 Jul;24(7):101003. doi: 10.1016/j.mcpro.2025.101003. Epub 2025 May 29.

Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease

Pokrzyk J, Kulczyńska-Przybik A, Guzik-Makaruk E, Winkel I, Mroczko B.

Int J Mol Sci. 2025 Feb 24;26(5):1935. doi: 10.3390/ijms26051935.

Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's disease

Panza F, Dibello V, Sardone R, Zupo R, Castellana F, Leccisotti I, Moretti MC, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Resta E, Lozupone M.

Expert Opin Biol Ther. 2025 Mar;25(3):275-283. doi: 10.1080/14712598.2025.2463963. Epub 2025 Feb 7.

Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated Tau in Alzheimer's disease

Shabana S, Hamouda HI, Shang A, Shao S, Zhao J, Yuan H, Liu B.

Alzheimers Res Ther. 2025 Dec 17;18(1):5. doi: 10.1186/s13195-025-01932-2.

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla L, Benejam B, Barroeta I, Fernandez S, Altuna M, Arranz J, Rodríguez-Baz Í, Arriola-Infante JE, Maure-Blesa L, Del Hoyo Soriano L, Illán-Gala I, Estellés T, Sanjuan A, Vaqué-Alcázar L, Aranha MR, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, Valldeneu S, Sánchez-Saudinós MB, Padilla C, Carreras M, Lorente O, Valle-Tamayo N, Sánchez-Aced É, Dols-Icardo O, Sirisi S, Muñoz L, Torres S, Bounasr El Bennadi SE, Sánchez O, Garzón D, Ribas L, Elbachiri S, Mota C, Tondo M, Camacho V, Giménez S, Delaby C, Belbin O, Iulita MF, Montal V, Pegueroles J, Vilaplana E, Clarimón J, González-Ortiz S, Molina-Porcel L, Aldecoa I, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Carmona-Iragui M, Fortea J.

Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.

Analytical considerations and clinical utility of plasma phosphorylated Tau217

Frykman H.

Crit Rev Clin Lab Sci. 2026 Mar;63(2):124-134. doi: 10.1080/10408363.2025.2551648. Epub 2025 Sep 15.

The moderating effect of cognitive reserve on the association between neuroimaging biomarkers and cognition: A systematic review

Guo L, Zhou Y, Lu H, Fung HH.

Neurobiol Aging. 2025 Dec;156:10-29. doi: 10.1016/j.neurobiolaging.2025.07.016. Epub 2025 Jul 30.

Utilizing machine learning algorithms to identify biomarkers associated with Alzheimer's disease and ferroptosis-related genes

Wang D, Lin C, Liu G, Wang X, Han S, Han Z.

Technol Health Care. 2025 Jul;33(4):2041-2063. doi: 10.1177/09287329251322278. Epub 2025 Mar 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias